ribavirin has been researched along with Cancer of Ovary in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carreiras, F; Cosson, F; Giffard, F; Kellouche, S; Laurent-Issartel, C; Leroy-Dudal, J; Lubin-Germain, N; Uziel, J; Wambecke, A | 1 |
| Deng, A; Jin, J; Wang, M; Wu, S; Xiang, W; Xiao, M | 1 |
| Albariño, CG; Bergeron, E; Khristova, ML; Nichol, ST | 1 |
| Look, KY; Singhal, RL; Sledge, GW; Weber, G; Yeh, YA | 1 |
| Monden, Y; Prajda, N; Taniki, T; Weber, G | 1 |
| Li, W; Weber, G | 1 |
| Herenyiova, M; Shen, F; Weber, G | 1 |
| Cooney, DA; Grusch, M; Jayaram, HN; Krupitza, G | 1 |
| Li, W; Prajda, N; Shen, F; Weber, G; Yang, H | 1 |
| Li, W; Shen, F; Weber, G | 1 |
| Abonyi, M; Li, W; Look, KY; Prajda, N; Shen, DF; Weber, G; Yang, H | 1 |
| Ban, J; Weber, G | 1 |
| Bosze, P; Eble, JN; Eckhardt, S; Ehrlich, CE; Look, KY; Natsumeda, Y; Olah, E; Prajda, N; Stehman, FB; Sutton, GP | 1 |
| Dobrynin, IaV; Lichinitser, MR; Lobova, TG; Nikolaeva, TG; Zharkov, SA | 1 |
| DiSaia, PJ; Kucera, PR; Micha, JP; Preve, CU; Rettenmaier, MA; Stratton, JA | 1 |
1 review(s) available for ribavirin and Cancer of Ovary
| Article | Year |
|---|---|
Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; cdc25 Phosphatases; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Guanosine Triphosphate; HL-60 Cells; Humans; IMP Dehydrogenase; Leukemia, Myeloid; Neoplasms; Nucleosides; Organoselenium Compounds; Ovarian Neoplasms; Protein Tyrosine Phosphatases; Ribavirin; Ribonucleosides; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1999 |
14 other study(ies) available for ribavirin and Cancer of Ovary
| Article | Year |
|---|---|
Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Ovarian Neoplasms; Ribavirin | 2019 |
Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cisplatin; Eukaryotic Initiation Factor-4E; Female; Humans; Mice, SCID; Molecular Targeted Therapy; Ovarian Neoplasms; Phosphorylation; Ribavirin; Signal Transduction | 2019 |
Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.
Topics: DNA-Directed RNA Polymerases; Female; Genome, Viral; Hemorrhagic Fever Virus, Crimean-Congo; Humans; Ovarian Neoplasms; Peptide Hydrolases; Protein Structure, Tertiary; Ribavirin; RNA, Viral; Virus Replication | 2010 |
Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells.
Topics: 1-Phosphatidylinositol 4-Kinase; Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Division; Depression, Chemical; Down-Regulation; Female; Humans; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Hairless; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Ovary; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Inbred ACI; Ribavirin; Signal Transduction; Tumor Cells, Cultured | 1994 |
Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Adenosquamous; Cell Division; Drug Screening Assays, Antitumor; Drug Synergism; Female; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Rats; Ribavirin; Spindle Apparatus; Tumor Cells, Cultured | 1993 |
Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma; Drug Screening Assays, Antitumor; Drug Synergism; Female; Genistein; Growth Inhibitors; Humans; Ovarian Neoplasms; Ribavirin; Tumor Cells, Cultured | 1998 |
Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells.
Topics: Antineoplastic Agents; Cell Cycle; Down-Regulation; Drug Synergism; Female; Humans; Inositol 1,4,5-Trisphosphate; Ovarian Neoplasms; Quercetin; Ribavirin; Signal Transduction; Tumor Cells, Cultured | 1999 |
Amplification of signal transduction capacity and down-regulation by drugs.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Differentiation; Cell Division; Colonic Neoplasms; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Genistein; Humans; Inositol Phosphates; Liver Neoplasms, Experimental; Neoplasms; Ovarian Neoplasms; Phosphoric Monoester Hydrolases; Rats; Ribavirin; Signal Transduction; Tamoxifen; Tumor Cells, Cultured | 1999 |
Ribavirin and quercetin synergistically downregulate signal transduction and are cytotoxic in human ovarian carcinoma cells.
Topics: Antineoplastic Agents; Antiviral Agents; Cell Cycle; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Multiple Myeloma; Ovarian Neoplasms; Quercetin; Ribavirin; Signal Transduction; Tumor Cells, Cultured | 1999 |
Signal transduction and biochemical targeting of ovarian carcinoma.
Topics: Cell Survival; Drug Synergism; Female; Genistein; Humans; Ovarian Neoplasms; Quercetin; Ribavirin; Signal Transduction | 2000 |
Synergistic action of tiazofurin and difluorodeoxycytidine on differentiation and cytotoxicity.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Cell Line; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gemcitabine; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Promyelocytic, Acute; Liver Neoplasms, Experimental; Models, Biological; Ovarian Neoplasms; Pancreatic Neoplasms; Rats; Ribavirin; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Stem Cell Assay | 1992 |
Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Guanosine Triphosphate; Humans; IMP Dehydrogenase; Middle Aged; Ovarian Neoplasms; Ovary; Ribavirin; Tissue Extracts | 1992 |
[Ribamidil as a modulator of the toxic effect of 5-fluorouracil].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cells, Cultured; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Ovarian Neoplasms; Ribavirin; Ribonucleosides | 1985 |
Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assay.
Topics: Animals; Antineoplastic Agents; Female; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Ovarian Neoplasms; Ribavirin; Ribonucleosides | 1985 |